Calgary

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment	Eosinophilia, Granuloma, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, asthma, autoimmune disease, bronchial disorder, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, obstructive lung disease, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis	Recruiting	Phase 3	2026-09-22		NCT07444567

Clinical trials